Cargando…
The Rise of Synaptic Density PET Imaging
Many neurological disorders are related to synaptic loss or pathologies. Before the boom of positrons emission tomography (PET) imaging of synapses, synaptic quantification could only be achieved in vitro on brain samples after autopsy or surgical resections. Until the mid-2010s, electron microscopy...
Autores principales: | Becker, Guillaume, Dammicco, Sylvestre, Bahri, Mohamed Ali, Salmon, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288098/ https://www.ncbi.nlm.nih.gov/pubmed/32422902 http://dx.doi.org/10.3390/molecules25102303 |
Ejemplares similares
-
In vivo exploration of synaptic projections in frontotemporal dementia
por: Salmon, Eric, et al.
Publicado: (2021) -
PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging
por: Toyonaga, Takuya, et al.
Publicado: (2022) -
Measuring brain synaptic vesicle protein 2A with positron emission tomography and [(18)F]UCB-H
por: Bahri, Mohamed Ali, et al.
Publicado: (2017) -
Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
por: Depierreux, Frédérique, et al.
Publicado: (2021) -
Evaluating the In Vivo Specificity of [(18)F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET
por: Serrano, Maria Elisa, et al.
Publicado: (2019)